Editas Medicine Inc Cash Flow Reinvestment Rate
Latest as of December 2019:
0.27x
Editas Medicine Inc cash flow reinvestment rate. Editas Medicine Inc (EDIT) has a Cash Flow Reinvestment Rate of 0.27x as of December 2019, reinvesting $11.13 Million (capex $1.69 Million plus investments $9.44 Million) from operating cash flow of $41.02 Million. Explore cash flow to debt ratio of Editas Medicine Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.27x
(Capex + Investments) / Operating CF
Total Reinvested
$11.13 Million
Capex + Investments
Operating Cash Flow
$41.02 Million
USD
Capital Expenditures
$1.69 Million
USD
Editas Medicine Inc Cash Flow Reinvestment Rate by Year (None–None)
Editas Medicine Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Editas Medicine Inc. For the full cash flow conversion analysis, see Editas Medicine Inc (EDIT) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow